255 related articles for article (PubMed ID: 25115387)
21. Blastic plasmacytoid dendritic cell neoplasm.
Lim D; Goodman H; Rademaker M; Lamont D; Yung A
Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
[TBL] [Abstract][Full Text] [Related]
22. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
23. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
Sapienza MR; Pileri S
Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
[TBL] [Abstract][Full Text] [Related]
24. Dendritic Cell Leukemia: a Review.
Tsagarakis NJ; Paterakis G
Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
[TBL] [Abstract][Full Text] [Related]
25. [Blastic plasmacytoid dendritic cell tumor treated with DVT regimen: a case report and literature review].
Shi J; Xu N; Niu Y; Jia SX; Yang CM; Fang MY
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):86-89. PubMed ID: 38527844
[TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
[TBL] [Abstract][Full Text] [Related]
27. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.
Julia F; Petrella T; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dereure O; Wetterwald M; d'Incan M; Grange F; Cornillon J; Tertian G; Maubec E; Saiag P; Barete S; Templier I; Aubin F; Dalle S
Br J Dermatol; 2013 Sep; 169(3):579-86. PubMed ID: 23646868
[TBL] [Abstract][Full Text] [Related]
28. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
Riaz W; Zhang L; Horna P; Sokol L
Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
[TBL] [Abstract][Full Text] [Related]
29. Blastic plasmacytoid dendritic cell neoplasm of the skin associated with myelodysplastic syndrome.
Kong QT; Zhang M; Sang H; Chen J; Yan W; Hu W; Deng D; Xie Q
Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780974
[TBL] [Abstract][Full Text] [Related]
30. Neoplasms derived from plasmacytoid dendritic cells.
Facchetti F; Cigognetti M; Fisogni S; Rossi G; Lonardi S; Vermi W
Mod Pathol; 2016 Feb; 29(2):98-111. PubMed ID: 26743477
[TBL] [Abstract][Full Text] [Related]
31. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings.
Zheng G; Schmieg J; Guan H; Ali SZ
Acta Cytol; 2012; 56(2):204-8. PubMed ID: 22378086
[TBL] [Abstract][Full Text] [Related]
32. Blastic Plasmocytoid Dendritic Cell Neoplasm With Skin and Myeloid Location.
Mizia-Malarz A; Sobol-Milejska G
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e29-e31. PubMed ID: 28060117
[TBL] [Abstract][Full Text] [Related]
33. Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Alfayez M; Konopleva M; Pemmaraju N
Expert Opin Biol Ther; 2020 Feb; 20(2):115-123. PubMed ID: 31801379
[No Abstract] [Full Text] [Related]
34. The distinctive cytology and disease evolution of blastic plasmacytoid dendritic cell neoplasm.
Fernandes F; Barreira R; Cortez J; Silveira M; Bain BJ
Am J Hematol; 2018 Nov; 93(11):1431-1432. PubMed ID: 30020546
[No Abstract] [Full Text] [Related]
35. Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms.
Emadali A; Hoghoughi N; Duley S; Hajmirza A; Verhoeyen E; Cosset FL; Bertrand P; Roumier C; Roggy A; Suchaud-Martin C; Chauvet M; Bertrand S; Hamaidia S; Rousseaux S; Josserand V; Charles J; Templier I; Maeda T; Bruder-Costa J; Chaperot L; Plumas J; Jacob MC; Bonnefoix T; Park S; Gressin R; Tensen CP; Mecucci C; Macintyre E; Leroux D; Brambilla E; Nguyen-Khac F; Luquet I; Penther D; Bastard C; Jardin F; Lefebvre C; Garnache F; Callanan MB
Blood; 2016 Jun; 127(24):3040-53. PubMed ID: 27060168
[TBL] [Abstract][Full Text] [Related]
36. A case report: Blastic plasmacytoid dendritic cell neoplasm is misdiagnosed as breast infiltrating ductal carcinoma.
Chen KC; Su TC; Chen DR; Liou JH
Int J Surg Pathol; 2015 Feb; 23(1):84-8. PubMed ID: 25297609
[TBL] [Abstract][Full Text] [Related]
37. TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm.
Jardin F; Ruminy P; Parmentier F; Troussard X; Vaida I; Stamatoullas A; Leprêtre S; Penther D; Duval AB; Picquenot JM; Courville P; Capiod JC; Tilly H; Bastard C; Marolleau JP
Br J Haematol; 2011 May; 153(3):413-6. PubMed ID: 21275969
[No Abstract] [Full Text] [Related]
38. Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia.
Bétrian S; Guenounou S; Luquet I; Demur C; Huynh A; Ysebaert L; Recher C; Huguet F
Hematol Oncol; 2017 Jun; 35(2):252-255. PubMed ID: 28620927
[TBL] [Abstract][Full Text] [Related]
39. Blastic Plasmacytoid Dendritic Cell Neoplasm: First Case Report From Rwanda and Review of the Literature.
Ruhangaza D; Mugabe MC; Kigonya CN; Lane AA; Morgan EA
J Glob Oncol; 2019 Jun; 5():1-6. PubMed ID: 31246550
[No Abstract] [Full Text] [Related]
40. Targeted diphtheria toxin to treat BPDCN.
FitzGerald DJ
Blood; 2014 Jul; 124(3):310-2. PubMed ID: 25035145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]